BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35626184)

  • 1. Unselected Population Genetic Testing for Personalised Ovarian Cancer Risk Prediction: A Qualitative Study Using Semi-Structured Interviews.
    Gaba F; Oxley S; Liu X; Yang X; Chandrasekaran D; Kalsi J; Antoniou A; Side L; Sanderson S; Waller J; Ahmed M; Wallace A; Wallis Y; Menon U; Jacobs I; Legood R; Marks D; Manchanda R
    Diagnostics (Basel); 2022 Apr; 12(5):. PubMed ID: 35626184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population Study of Ovarian Cancer Risk Prediction for Targeted Screening and Prevention.
    Gaba F; Blyuss O; Liu X; Goyal S; Lahoti N; Chandrasekaran D; Kurzer M; Kalsi J; Sanderson S; Lanceley A; Ahmed M; Side L; Gentry-Maharaj A; Wallis Y; Wallace A; Waller J; Luccarini C; Yang X; Dennis J; Dunning A; Lee A; Antoniou AC; Legood R; Menon U; Jacobs I; Manchanda R
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32429029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based genetic risk prediction and stratification for ovarian cancer: views from women at high risk.
    Rahman B; Meisel SF; Fraser L; Side L; Gessler S; Wardle J; Lanceley A
    Fam Cancer; 2015 Mar; 14(1):135-44. PubMed ID: 25391615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latinx individuals' knowledge of, preferences for, and experiences with prenatal genetic testing: a scoping review.
    Grafft N; Dwyer AA; Pineros-Leano M
    Reprod Health; 2022 Jun; 19(1):134. PubMed ID: 35668466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing patients' decision-making about preimplantation genetic testing for monogenic disorders.
    Cheng L; Meiser B; Kirk E; Kennedy D; Barlow-Stewart K; Kaur R
    Hum Reprod; 2022 Oct; 37(11):2599-2610. PubMed ID: 36006036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perceptions, motivations and decision regret surrounding preimplantation genetic testing for aneuploidy.
    Kaing A; Rosen MP; Quinn MM
    Hum Reprod; 2020 Sep; 35(9):2047-2057. PubMed ID: 32756971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient decision aids in mainstreaming genetic testing for women with ovarian cancer: A prospective cohort study.
    Sobocan M; Chandrasekaran D; Sideris M; Blyuss O; Fierheller C; Kalra A; Sia J; Miller RE; Mills-Baldock T; Crusz SM; Sun L; Evans O; Robbani S; Jenkins LA; Ahmed M; Kumar A; Quigley M; Lockley M; Faruqi A; Casey L; Brockbank E; Phadnis S; Trevisan G; Singh N; Legood R; Manchanda R
    BJOG; 2024 May; 131(6):848-857. PubMed ID: 37752678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitude towards and factors affecting uptake of population-based BRCA testing in the Ashkenazi Jewish population: a cohort study.
    Manchanda R; Burnell M; Gaba F; Sanderson S; Loggenberg K; Gessler S; Wardle J; Side L; Desai R; Brady AF; Dorkins H; Wallis Y; Chapman C; Jacobs C; Tomlinson I; Beller U; Menon U; Jacobs I
    BJOG; 2019 May; 126(6):784-794. PubMed ID: 30767407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond the biopsy: predictors of decision regret and anxiety following preimplantation genetic testing for aneuploidy.
    Goldman KN; Blakemore J; Kramer Y; McCulloh DH; Lawson A; Grifo JA
    Hum Reprod; 2019 Jul; 34(7):1260-1269. PubMed ID: 31220868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproductive decision-making and the utilization of preimplantation genetic testing among individuals with inherited aortic or vascular disease.
    Patton K; Wong EK; Cirino AL; Dobson LJ; Harris S
    J Genet Couns; 2023 Aug; ():. PubMed ID: 37533143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review on the motivations, decision-making factors, attitudes and experiences of couples using pre-implantation genetic testing for inherited conditions.
    Hughes T; Bracewell-Milnes T; Saso S; Jones BP; Almeida PA; Maclaren K; Norman-Taylor J; Johnson M; Nikolaou D
    Hum Reprod Update; 2021 Aug; 27(5):944-966. PubMed ID: 33969393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes towards risk-reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention: a cohort study.
    Gaba F; Blyuss O; Chandrasekaran D; Osman M; Goyal S; Gan C; Izatt L; Tripathi V; Esteban I; McNicol L; Ragupathy K; Crawford R; Evans DG; Legood R; Menon U; Manchanda R
    BJOG; 2021 Mar; 128(4):714-726. PubMed ID: 32803845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploration of decision-making regarding the transfer of mosaic embryos following preimplantation genetic testing: a qualitative study.
    Cheng L; Meiser B; Kennedy D; Kirk E; Barlow-Stewart K; Kaur R
    Hum Reprod Open; 2022; 2022(4):hoac035. PubMed ID: 36157005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health care professionals' attitudes towards population-based genetic testing and risk-stratification for ovarian cancer: a cross-sectional survey.
    Hann KEJ; Fraser L; Side L; Gessler S; Waller J; Sanderson SC; Freeman M; Jacobs I; Lanceley A;
    BMC Womens Health; 2017 Dec; 17(1):132. PubMed ID: 29246147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-based Genetic Testing for Precision Prevention.
    Evans O; Manchanda R
    Cancer Prev Res (Phila); 2020 Aug; 13(8):643-648. PubMed ID: 32409595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An intervention to improve the quality of life in children of parents with serious mental illness: the Young SMILES feasibility RCT.
    Abel KM; Bee P; Gega L; Gellatly J; Kolade A; Hunter D; Callender C; Carter LA; Meacock R; Bower P; Stanley N; Calam R; Wolpert M; Stewart P; Emsley R; Holt K; Linklater H; Douglas S; Stokes-Crossley B; Green J
    Health Technol Assess; 2020 Nov; 24(59):1-136. PubMed ID: 33196410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "It wasn't just for me": Motivations and implications of genetic testing for women at a low risk of hereditary breast and ovarian cancer syndrome.
    Gill G; Beard C; Storey K; Taylor S; Sexton A
    Psychooncology; 2020 Aug; 29(8):1303-1311. PubMed ID: 32497346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review exploring the patient decision-making factors and attitudes towards pre-implantation genetic testing for aneuploidy and gender selection.
    Bracewell-Milnes T; Saso S; Jones B; Cato S; Parikh R; Thum MY; Johnson M; Almeida P; Norman-Taylor J; Nikolaou D
    Acta Obstet Gynecol Scand; 2021 Jan; 100(1):17-29. PubMed ID: 32862440
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.